Status:

COMPLETED

Women in Steady Exercise Research [Formerly Women, Oxidative Stress, Exercise and Estrogens (WOSEE)]

Lead Sponsor:

University of Minnesota

Collaborating Sponsors:

National Cancer Institute (NCI)

Conditions:

Breast Cancer

Obesity

Eligibility:

FEMALE

18-30 years

Phase:

PHASE2

PHASE3

Brief Summary

RATIONALE: Exercising regularly may lower the risk of breast cancer. PURPOSE: This randomized clinical trial is studying how well exercise prevents breast cancer in healthy young women.

Detailed Description

OBJECTIVES: Primary * Compare the changes in urine levels of a stable marker of oxidative stress (F\_2-isoprostanes) in healthy young women who undergo exercise training during 4 menstrual cycles vs...

Eligibility Criteria

Inclusion

  • Healthy women
  • Self-reported menstrual cycle length of 25-35 days within the past 2 months
  • Nonsmoker
  • Sedentary (exercise \< 3 times weekly within the past 6 months)
  • Intact ovaries and uterus
  • No history of gynecological problems (e.g., fibroids, endometriosis, polycystic ovary syndrome)
  • Female
  • Premenopausal
  • Body mass index 18.5 to 40
  • Stable weight (no changes ≥ 10% within the past year)

Exclusion

  • No pregnancy or breast feeding within the past 6 months
  • No plans to become pregnant during study treatment
  • No cancer within the past 5 years except for nonmelanoma skin cancers
  • No medical condition that would prohibit participation in a vigorous program of weight-bearing aerobic exercise including, but not limited to, any of the following:
  • Fibromyalgia
  • Chronic fatigue syndrome
  • Metabolic disorders
  • Recent cardiovascular event
  • Orthopedic limitations
  • Psychiatric disorders requiring antipsychotic drugs
  • No uncontrolled hypertension (systolic blood pressure \[BP\] \> 160 mm Hg and/or diastolic BP \> 99 mm Hg)
  • No more than 7 alcoholic beverages per week
  • No injected hormonal contraceptive use within the past year
  • More than 6 months since prior use of intrauterine device
  • More than 3 months since prior oral or patch hormone contraceptives
  • No medication that would prohibit participation in a vigorous program of weight-bearing aerobic exercise

Key Trial Info

Start Date :

May 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2010

Estimated Enrollment :

400 Patients enrolled

Trial Details

Trial ID

NCT00393172

Start Date

May 1 2006

End Date

March 1 2010

Last Update

November 1 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Minnesota - St. Paul Campus

Saint Paul, Minnesota, United States, 55108